Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease

BACKGROUND: We aimed to assess the efficacy of different initial intravenous immunoglobulin (IVIG) regimens in Kawasaki disease (KD) patients to find more cost‐effective therapy options. METHODS: A multicenter, open‐label, blind‐endpoint randomized controlled trial was conducted from January 2014 to...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lan, Liu, Fang, Yan, Weili, Huang, Min, Huang, Meirong, Xie, Lijian, Guo, Ying, Xu, Xinyi, Chu, Chen, Wu, Lin, Liang, Xuecun, Sun, Shuna, Wang, Feng, Zhao, Lu, Zhao, Quming, Ma, Xiaojing, Xie, Liping, Huang, Guoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362187/
https://www.ncbi.nlm.nih.gov/pubmed/33600060
http://dx.doi.org/10.1111/ped.14656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362187/
https://www.ncbi.nlm.nih.gov/pubmed/33600060
http://dx.doi.org/10.1111/ped.14656

Ejemplares similares